Is PharmaResearch Co., Ltd. stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, PharmaResearch Co., Ltd. pays dividends. Last time was Thursday 18th of April 2024 where the investors holding the stock on Wednesday 27th of December 2023 were paid KRW660 per share. Over the last 4 times between 2015 and 2023, PharmaResearch Co., Ltd. has paid KRW1820 with an average of KRW455 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for PharmaResearch Co., Ltd. 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was KRW33 650, you would have made a profit of KRW192 350 per share or 571.62%
Yes, the average daily trading liquidity for PharmaResearch Co., Ltd. is KRW242 987 thousand. You should therefore be able to get in and out of your positions relatively fast.
PharmaResearch Co., Ltd. has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 3.05, the company's ability to pay off the debt is good. PharmaResearch Co., Ltd. has a very good net profit margin of 30.60% and should have very high tolerances against inflation.
We have calculated the inflation risk for PharmaResearch Co., Ltd. to be low [0 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.